Trial Profile
Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Patients With Severe Motor Involvement at Subacute Phase of Stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms E-COMPASSII
- 18 Sep 2019 Status changed from recruiting to completed.
- 04 May 2018 New trial record